PRK (July 2025)/ CME GLOBEX
PRK- - | Chg. - | Open | High | Low | Previous Close |
---|---|---|---|---|---|
-USD | - | - | - | - | - |
GlobeNewswire
7/22/2024
Park National Corporation reports financial results for second quarter and first half of 2024
GlobeNewswire
5/21/2024
Park National Corporation welcomes Kelly Gratz and Karen Morrison to Board of Directors
GlobeNewswire
4/11/2024
First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS...
GlobeNewswire
1/19/2024
Regency Centers Announces Tax Information for Regency Centers and Urstadt Biddle Properties 2023 Dis...
GlobeNewswire
10/23/2023
Park National Corporation reports financial results for third quarter and first nine months of 2023
GlobeNewswire
3/28/2022
EVO VISIAN® ICL NOW AVAILABLE IN THE US: PARKHURST NUVISION OF SAN ANTONIO TEXAS AMONG FIRST IN THE ...
GlobeNewswire
12/21/2021
Park National Corporation welcomes D. Byrd Miller III to Board of Directors
GlobeNewswire
11/15/2021
Kiora Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
11/8/2021
EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s Sharpened Clinical Development St...
GlobeNewswire
10/29/2021
Physician Growth Partners Advises Griffey Eye Care & Their Affiliated Entities in a Partnership With...
GlobeNewswire
10/26/2021
EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes A...
GlobeNewswire
10/25/2021
Park National Corporation reports financial results for third quarter and first nine months of 2021
GlobeNewswire
10/4/2021
Agrify Acquires Precision Extraction Solutions and Cascade Sciences, Two of the Leading Cannabis and...
GlobeNewswire
9/9/2021
EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
9/8/2021
EyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for ...
GlobeNewswire
7/30/2021
Park National Corporation welcomes Dr. Frederic Bertley to board of directors
GlobeNewswire
7/26/2021
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Execu...
GlobeNewswire
7/26/2021
Park National Corporation reports financial results for second quarter and first half of 2021
GlobeNewswire
4/26/2021
Park National Corporation leader Daniel DeLawder announces retirement after 50 years of service